Vericel Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Vericel Corp.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
/ 
Frequently asked questions
To buy Vericel Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Vericel Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Vericel Corp. is VCEL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Vericel Corp. has its primary listing on NASDAQ (Small cap). You can trade Vericel Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Vericel Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Vericel Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Vericel Corp..